Sanofi Consumer Healthcare India block deals, bulk deals, insider trading and stake changes
NSE: SANOFICONRBSE: 544250Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,262.80.
- Next results date: the board meets on 28 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹7,388 Cr551st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 27.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 Jul 2026
- 21.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.34%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 87.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- 97.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026. The filing of 28 Jul 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 15,77169.2% delivered
Sanofi Consumer Healthcare India insider trading
All 5 disclosures on record. The company's own latest disclosure on record is from Jun 2025.Insider trading, all companies
Jun 2025
- Opal Bidco SAS₹1,248 Cr25,04,630 sharesReceived · Promoter Group · 11 Jun 2025 · disclosed 12 Jun · Off Market · holds 25,04,630 after, stake 10.87% after
Oct 2024
- Opella Healthcare Participations B.V.₹2.33 Cr4,865 sharesReceived · Promoters · 25 Oct 2024 · Inter-se-Transfer · stake 60.37% before, 60.40% after
- SANOFI₹2.33 Cr4,865 sharesGave · Promoters · 25 Oct 2024 · Inter-se-Transfer · held 4,865 before
- Hoechst GmbH₹6,927 Cr1,39,04,722 sharesGave · Promoters · 10 Oct 2024 · disclosed 11 Oct · Inter-se-Transfer · held 1,39,04,722 before
- Opella Healthcare Participations B.V.₹6,927 Cr1,39,04,722 sharesReceived · Promoter Group · 10 Oct 2024 · disclosed 11 Oct · Inter-se-Transfer · holds 1,39,04,722 after, stake 60.37% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Sanofi Consumer Healthcare India stake sales and purchases
All 7 disclosures on record.
Apr 2026
- AcquiredNippon India Mutual Fund0.13% of the company30,000 sharesholds 5.05% after29 Apr 2026 · filed under the 5% rule · Open Market
Jun 2025
- AcquiredOpal Bidco SAS · promoter10.87% of the company25,04,630 sharesholds 10.87% after11 Jun 2025 · filed under the 5% rule
Oct 2024
- SoldSanofi · promoter0.02% of the company4,865 sharesholds none after25 Oct 2024 · filed under the 2% rule · Inter-se transfer
- AcquiredOpella Healthcare Participations B. V · promoter0.02% of the company4,865 sharesholds 60.40% after25 Oct 2024 · filed under the 2% rule · Inter-se transfer
- SoldHoechst GmbH · promoter60.37% of the company1,39,04,722 sharesholds none after10 Oct 2024 · filed under the 2% rule · Inter-se transfer
- AcquiredOpella Healthcare Participations B. V · promoter60.37% of the company1,39,04,722 sharesholds 60.37% after10 Oct 2024 · filed under the 5% rule · Inter-se transfer
Sep 2024
- AcquiredSanofi SA · promoter60.40% of the company1,39,09,587 sharesholds 60.40% after13 Sep 2024 · filed under the 5% rule
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Sanofi Consumer Healthcare India block deals and bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 10 Oct 20244 firms · ₹13,855 Cr bought · ₹13,855 Cr soldNet nil
- SoldHOECHST GMBHBlock dealSold 1,39,04,722 at ₹4,982.0560.37% of the company₹6,927 Cr
- SoldHOECHST GMBHSold 1,39,04,722 at ₹4,982.0560.37% of the company₹6,927 Cr
- BoughtOPELLA HEALTHCARE PARTICIPATIONS B VBlock dealBought 1,39,04,722 at ₹4,982.0560.37% of the company₹6,927 Cr
- BoughtOPELLA HEALTHCARE PARTICIPATIONS B VBought 1,39,04,722 at ₹4,982.0560.37% of the company₹6,927 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 2 deals on record since listing on 13 Sep 2024.